drugset / Trial / NCT04867551
A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
Objective of this study is to investigate the safety, pharmacokinetics and efficacy of KDT-3594 in patients with early Parkinson's disease without a concomitant medication of L-dopa.
Timeline
- Start
- 2021-05-15
- Primary completion
- 2021-09-06
- Completion
- 2021-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KDT-3594 | Unknown | — | Oral |